Otsuka Group News

Keyword search

Search by company	Otsuka Holdings Otsuka Pharmaceutical Otsuka Pharmaceutical Factory Taiho Pharmaceutical Otsuka Warehouse Otsuka Chemical Otsuka Foods Otsuka Medical Devices Other
Search by category^*	Pharmaceuticals Business Nutraceuticals Business Consumer Products Business Others Products R&D Personnel Corporate * Business categories are based on the business segments described in the financial announcements.
Search by release date	-

May 26, 2025
Otsuka Pharmaceutical

Otsuka Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN)
May 23, 2025
Taiho Pharmaceutical

Cullinan Therapeutics, Taiho Pharmaceutical, and Taiho Oncology to Present Positive Results from Pivotal Phase 2b REZILIENT1 Trial of Zipalertinib at ASCO 2025
May 23, 2025
Taiho Pharmaceutical

Results of Clinical Study of the Combination Regimen of Decitabine and Cedazuridine Plus Venetoclax for Acute Myeloid Leukemia Announced at the American Society of Clinical Oncology Annual Meeting
May 9, 2025
Otsuka Pharmaceutical

Pharmavite Established a New Facility in Ohio, US, Dedicated to The Manufacturing of Gummy Supplements Facilitating the Research and Development of Gummy Products
May 8, 2025
Otsuka Pharmaceutical

Otsuka Signs Joint Research Agreement with Keio University Industry-academia collaboration for infrastructure development toward the social implementation of psychedelics in Japan
May 2, 2025
Otsuka Pharmaceutical Factory

Otsuka Pharmaceutical Factory America, Inc. Acquires 60% Interest in Otsuka ICU Medical LLC and Subsidiarizes
April 15, 2025
Otsuka Pharmaceutical

Otsuka Pharmaceutical Opens First POCARI SWEAT Factory in Vietnam Supporting Health and Meeting Growing Demand
April 1, 2025
Otsuka Pharmaceutical

Otsuka Pharmaceutical is Focusing on "Water, Nutrition, and Oxygen" to Tap into Human Potential Provide "Wellness Energy" at Expo 2025 in Osaka, Kansai, Japan
March 31, 2025
Otsuka Pharmaceutical Factory

J.O. Pharma installs electricity from renewable sources to contribute to a decarbonized society
March 31, 2025
Otsuka Pharmaceutical

Otsuka Files Biologics License Application (BLA) for Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy
March 28, 2025
Otsuka Holdings

Otsuka Holdings appoints Board Members and Auditors and Supervisory Board Members
March 24, 2025
Otsuka Pharmaceutical Factory

Announcement of Price Revisions for Oronine H Ointment
March 17, 2025
Taiho Pharmaceutical

Taiho Pharmaceutical to Acquire Next-Generation ADC Drug Discovery Company Araris Biotech
March 14, 2025
Otsuka Pharmaceutical

Otsuka Pharmaceutical is Expanding “Local Production and Local Recycling” of PET Bottle Initiatives in Cooperation with Local Communities Agreement Signed with the Saga Eastern Environmental Facilities Association for Horizontal Recycling of PET Bottles
March 13, 2025
Otsuka Pharmaceutical

Rxulti® (brexpiprazole) approved in the European Union for the treatment of schizophrenia in adolescents aged 13 years and older
March 13, 2025
Otsuka Foods

Otsuka Foods to Introduce 100% Recycled PET Bottles for JAVA TEA Lessening Environmental Impact by Reducing CO₂ Emissions to Contribute to a Sustainable Society
March 13, 2025
Otsuka Holdings

Publication of Otsuka Health Comic Library “What are Medicines for?” Celebrating 35 years of helping to boost child health literacy
March 12, 2025
Otsuka Holdings

Otsuka Holdings Receives Award for Excellence for the First Time at the NIKKEI Integrated Report Award 2024
March 3, 2025
Otsuka Pharmaceutical

SOYJOY Black Sesame A Bold Sesame Experience with a Delightful Popping Texture and Roasted Aroma
March 3, 2025
Otsuka Pharmaceutical

HemeSight®, the First-in-Japan Comprehensive Genomic Profiling Assay for Hematological Malignancies, Is Now on Sale - Insurance coverage begins on March 1, 2025 -
February 26, 2025
Otsuka HoldingsTaiho Pharmaceutical

Solar Power Generation Facility Launched at Taiho Pharmaceutical’s Kitajima Plant to Accelerate Carbon Neutrality Initiatives
February 26, 2025
Otsuka Foods

Otsuka Foods to Release 100kcal “My Size Plus Support, 1g Salt Chuka-don” and “100kcal My Size Plus Support, 1g Salt Mabo-don” Two Delicious Products Designed to Help Solve Japan’s Health Issue of Too Much Dietary Salt Available at Drugstores, Pharmacies and Other Outlets Nationwide Starting March 17, 2025
February 20, 2025
Otsuka Pharmaceutical

Otsuka Sponsor TOKYO MARATHON 2025 Supporting the Conditioning of Runners Worldwide with the Global Brand POCARI SWEAT
February 19, 2025
Otsuka HoldingsOtsuka Pharmaceutical

Otsuka Holdings Receives Award by the Commissioner of the Consumer Affairs Agency at FY2024 Award for Good Practices of Consumer-Oriented Management　- Recognized for Otsuka Pharmaceutical’s Longstanding Efforts to Prevent Heat Disorders-
February 18, 2025
Otsuka Foods

Otsuka Foods to Release Mannan Gohan with Glutinous Barley and Brown Rice Providing Approx. Five Times the Dietary Fiber of White Rice or Half the Recommended Daily Intake In Stores Across Japan on March 3, 2025
February 14, 2025
Otsuka Holdings

Otsuka Holdings Announces Personnel Changes
February 14, 2025
Otsuka Pharmaceutical

Otsuka Pharmaceutical to Offer "Wellness Energy" at the Expo 2025 Osaka, Kansai, Japan Introducing a New Vision for “Shaping the Health of the Future”
February 13, 2025
Otsuka Pharmaceutical

Otsuka Pharmaceutical Finalizes an Agreement with Fukuroi City on the Horizontal Recycling of PET Bottles Partnering with Its Factory to Promote a “Local Production and Local Recycling” Initiative for PET Bottles
February 7, 2025
Otsuka Holdings

Otsuka Group Selected for CDP Climate Change A List for a Third Consecutive Year
February 5, 2025
Otsuka Foods

Otsuka Foods to Release “Bon Curry NEO Ninniku Mashi Mashi: Hot” Enhanced Umami with Double the Garlic, Beef Sauteed in Red Wine, and a Rich Sauce In Stores across Japan from March 17, 2025

Otsuka Group News

First 30 results